close icon

Pandora Stock Shining Bright Again Despite Pandemic

We last wrote about Pandora A/S in late-July, 2019. The stock was hovering around DKK 260 after a long and painful decline from over DKK 1000 in 2016. But business-wise, the Danish jewelry-maker was taking the right steps to fix things and straighten the ship.

Program NOW was initiated in 2019 to cut costs and improve in-store and online experience. Alexander Lacik was appointed CEO a few months later to help with the turnaround and brand relaunch. Shortly after that we took a look at Pandora’s stock price chart…

Pandora Completes Negative Phase of Elliott Wave cycle

…and found an Elliott Wave cycle there. The pattern had been in progress since 2011. There was a clear impulsive rally, labeled (1)-(2)-(3)-(4)-(5), where the five sub-waves of wave (3) were also visible. But since the theory states that a three-wave correction follows every impulse, Pandora’s surge couldn’t possibly continue.

Ahead of Pandora ‘s Successful Turnaround with Elliott Wave

The stock reflected the deteriorating fundamentals of the business and by the time of our previous article was trading at DKK 261. The correction looked like a complete (a)-(b)-(c) zigzag, which made us think the bulls can return right away. “Not so fast”, said COVID-19.

Pandora jumps 260% in nine months since March 2020

Needless to say, when we made that analysis we had no idea that a global coronavirus pandemic was on its way. The February-March selloff interrupted Pandora’s recovery and caused a new low of DKK 180. It changed the structure of the correction from a simple (a)-(b)-(c) to a triple (w)-(x)-(y)-(x)-(z) zigzag.

It did not, however, change our long-term bullish outlook on Pandora. And since the company was financially stable and we don’t use leverage to invest in stocks, the COVID drop didn’t matter that much. The recovery might have been postponed but not cancelled.

Pandora stock closed at DKK 653 today, up 150% since our July 30, 2019 article. Investors who had the courage and resources to buy in March did even better. Of course, it is highly unlikely that the post-March surge can continue in a straight line. There will be retracements along the way. As long as the fundamentals and Elliott Wave analysis continue to confirm the bullish thesis, we will view these as buying opportunities.

Similar Elliott Wave setups occur in the Forex, crypto and commodity markets, as well. Our Elliott Wave Video Course can teach you how to uncover them yourself!

Stay informed with our newsletter

Latest Elliott Wave analysis on different topics delivered to you weekly.

Privacy policy
You may also like:

Undervalued Bristol Myers Stock Can Still Get Cheaper

It’s been almost two years since we shared our bullish stance on Bristol Myers stock. Shares in the pharmaceutical major were changing hands for less than $46 in April, 2019. The company had just announced its planned acquisition of Celgene for about $74 billion and Wall Street apparently didn’t like the risks involved. However, the…

Read More »

DraftKings on the Verge of Another 40% Decline

It’s been almost three and a half months since we examined DraftKings stock in October, 2020. The share price was hovering near $57 after a strong run from $10.60 to over $64 in just several months. The regulatory environment in the U.S. seemed to be warming up and many analysts hurried to issue their BUY…

Read More »

AMN Healthcare Stock to Suffer a 2020-Like Drop

AMN Healthcare Services provides workforce and staffing solutions to healthcare facilities in the U.S. The company is relatively small with a market capitalization of less than $4 billion. However, small companies can make for excellent returns if one happens to identify the winners. And indeed, between late-2011 and early-2020, AMN stock from under $4 to…

Read More »

Zoetis Stock Getting Ahead of Itself, Invites Correction

Based in Parsippany, NJ, Zoetis Inc. is an animal medicine and vaccine developer and manufacturer. The company went public in 2013 and has been enjoying steady growth since. With the stock currently above $160 a share, Zoetis holds a market cap of nearly $80 billion. For a profitable and growing company like Zoetis, a rising…

Read More »

CBOE Stock Looking Good After a Record Year

CBOE Global Markets Inc. is an equities, options and futures exchange operator in the U.S. and Europe. The company traces its roots back to Chicago in 1973, when it practically invented options trading in its present form. CBOE is literally part of the very infrastructure of modern financial markets. So it is not surprising that…

Read More »

Novo Nordisk Bulls Have an Elliott Wave Problem

Novo Nordisk A/S is a Danish pharmaceuticals major with a market cap of over $160 billion. People need their medication even in recessions, so the company’s business wasn’t as affected by the 2020 crisis as most other industries. Novo Nordisk remains a top-notch pharma with consistent profits and revenue and no debt whatsoever. And the…

Read More »

Lockheed ‘s Correction Still Unfolding as Expected

Almost a year and a half ago, in July 2019, we wrote that Lockheed Martin is likely “setting the stage for an unpleasant surprise.” The stock had just reached a new all-time high and was trading at $370 a share. Optimism was in the air and analysts were more bullish than ever. An indeed, fundamentally,…

Read More »

More analyses